Skip Navigation



JAC Advance Access published online on June 20, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl258
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
58/3/557    most recent
dkl258v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lecároz, C.
Right arrow Articles by Blanco-Prieto, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lecároz, C.
Right arrow Articles by Blanco-Prieto, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received April 3, 2006
Revised May 23, 2006
Accepted May 30, 2006

Original article

Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method

Concepción Lecároz 1, Miguel A. Campanero 2, Carlos Gamazo 1, and María J. Blanco-Prieto 3 *

1 Department of Microbiology, University of Navarra, Pamplona, Spain
2 Department of Clinical Pharmacology, Clínica Universitaria, Pamplona, Spain
3 Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31080 Pamplona, Spain

* To whom correspondence should be addressed.
María J. Blanco-Prieto, E-mail: mjblanco{at}unav.es


  Abstract

Objectives: The aim of this work was to develop and validate an HPLC method for gentamicin quantification in different types of biological samples such as animal tissues and cellular material and also in pharmaceuticals.

Methods: Poly(lactide-co-glycolide) microparticles (MP) of gentamicin (PLGA 502H MP), THP-1 cells, and plasma and tissue samples of mice treated with the antibiotic either free or loaded into PLGA 502H MP were processed by a simple preparation procedure, subjected to chromatography on a reversed-phase column and measured by mass spectrometry detection. The developed method was compared with bioassay and fluorimetric assay methods previously used for gentamicin determination.

Results: The HPLC method was linear over the ranges 40-800 ng/mL and 0.1-100 µg/mL and showed good accuracy (average accuracy < 5.59%) and reproducibility (CV < 6.13%). Encapsulation of gentamicin in PLGA 502H MP was determined by the three methods. Good correlation was observed between bioassay (reference method) and HPLC. Extra- and intracellular in vitro antibiotic accumulation was determined by bioassay and chromatography. Both methods gave similar extracellular concentrations but the HPLC-MS technique demonstrated an improved accuracy (5.59% versus 14%) and precision (6.13% versus 15%) compared with bioassay. However, only the HPLC-MS method was sensitive enough to detect the drug, intracellularly and in tissues.

Conclusions: All these data favour the use of chromatography-mass spectrometry as a versatile technique not only suitable for gentamicin quantification loaded in drug delivery systems, but also sensitive and specific enough for in vivo and intracellular studies.

Keywords: HPLC-MS; bioassay; fluorimetric assay; cellular quantification; biological matrices; drug delivery systems; PLGA.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
M. C. Lecaroz, M. J. Blanco-Prieto, M. A. Campanero, H. Salman, and C. Gamazo
Poly(D,L-Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics in Brucella melitensis- Infected Mice
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.